{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:59:44Z","timestamp":1773813584212,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"London research consortium"},{"name":"Wellcome Trust Strategic Award","award":["098330\/Z\/12\/Z"],"award-info":[{"award-number":["098330\/Z\/12\/Z"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.neulet.2016.11.023","type":"journal-article","created":{"date-parts":[[2016,11,13]],"date-time":"2016-11-13T05:01:03Z","timestamp":1479013263000},"page":"254-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Cognitive ability in Down syndrome and its relationship to urinary neopterin, a marker of activated cellular immunity"],"prefix":"10.1016","volume":"636","author":[{"given":"Panagiotis","family":"Zis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Strydom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Adekitan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick C.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neulet.2016.11.023_bib0005","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.3233\/JAD-2010-100498","article-title":"Reactive oxygen species: stuck in the middle of neurodegeneration","volume":"20","author":"Patten","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2016.11.023_bib0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3233\/JAD-2009-1041","article-title":"Oxidative stress in vascular dementia and Alzheimer\u2019s disease: a common pathology","volume":"17","author":"Bennett","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2016.11.023_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NEN.0b013e3181cb5af4","article-title":"Oxidative stress in the progressionof Alzheimer disease in the frontal cortex","volume":"69","author":"Ansari","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"September (9)","key":"10.1016\/j.neulet.2016.11.023_bib0020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2016.11.023_bib0025","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(03)12987-X","article-title":"Down\u2019s syndrome","volume":"361","author":"Roizen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2016.11.023_bib0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10519-006-9047-x","article-title":"Neuroanatomy of Down syndrome in vivo: a model of preclinical Alzheimer\u2019s disease","volume":"36","author":"Teipel","year":"2006","journal-title":"Behav. Genet."},{"issue":"December (6)","key":"10.1016\/j.neulet.2016.11.023_bib0035","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1037\/0735-7044.115.6.1239","article-title":"Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease","volume":"115","author":"Hyde","year":"2001","journal-title":"Behav. Neurosci."},{"issue":"10","key":"10.1016\/j.neulet.2016.11.023_bib0040","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.biopsych.2010.04.010","article-title":"Amelioration of the Alzheimer's disease phenotype by absence of 12\/15-lipoxygenase","volume":"68","author":"Yang","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neulet.2016.11.023_bib0045","first-page":"63","article-title":"Elevated urinary neopterin suggests immune activation in Alzheimer\u2019s disease and Down\u2019s syndrome","volume":"14","author":"Armstrong","year":"1994","journal-title":"Neurosci. Res. Commun."},{"issue":"February (2)","key":"10.1016\/j.neulet.2016.11.023_bib0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/gps.3802","article-title":"Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease","volume":"28","author":"Parker","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"May","key":"10.1016\/j.neulet.2016.11.023_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2016.01.014","article-title":"No relationship between lipoprotein-associated phospholipase A2, proinflammatory cytokines, and neopterin in Alzheimer's disease","volume":"77","author":"Savas","year":"2016","journal-title":"Exp. Gerontol."},{"issue":"July (1\u20132)","key":"10.1016\/j.neulet.2016.11.023_bib0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jneuroim.2005.03.010","article-title":"Increased serum neopterin levels in adults with Down syndrome","volume":"164","author":"Mehta","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"March (3)","key":"10.1016\/j.neulet.2016.11.023_bib0065","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00726-009-0300-5","article-title":"Plasma levels of nitric oxide related amino acids in demented subjects with Down syndrome are related to neopterin concentrations","volume":"38","author":"Coppus","year":"2010","journal-title":"Amino Acids"},{"issue":"March (1\u20132)","key":"10.1016\/j.neulet.2016.11.023_bib0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2006.12.010","article-title":"Increased amyloid beta protein levels in children and adolescents with Down syndrome","volume":"254","author":"Mehta","year":"2007","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.neulet.2016.11.023_bib0075","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00702-007-0656-1","article-title":"Plasma amino acids and neopterin in healthy persons with Down's syndrome","volume":"114","author":"Coppus","year":"2007","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.neulet.2016.11.023_bib0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/8904_2012_144","article-title":"Urinary neopterin and phenylalanine loading test as tools for the biochemical diagnosis of segawa disease","volume":"7","author":"Leuzzi","year":"2013","journal-title":"JIMD Rep."},{"issue":"1","key":"10.1016\/j.neulet.2016.11.023_bib0085","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pnpbp.2008.10.006","article-title":"Oxidative stress and cognitive ability in adults with Down syndrome","volume":"33","author":"Strydom","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"issue":"2","key":"10.1016\/j.neulet.2016.11.023_bib0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-2012-120073","article-title":"Oxidative stress and memory decline in adults with Down syndrome: longitudinal study","volume":"31","author":"Zis","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"June (6)","key":"10.1016\/j.neulet.2016.11.023_bib0095","doi-asserted-by":"crossref","first-page":"e97709","DOI":"10.1371\/journal.pone.0097709","article-title":"Memory decline in Down syndrome and its relationship to iPF2alpha, a urinary marker of oxidative stress","volume":"9","author":"Zis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2016.11.023_bib0100","series-title":"Adaptive Behaviour Assessment System (ABAS)","author":"Harrison","year":"2000"},{"key":"10.1016\/j.neulet.2016.11.023_bib0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2788.1996.tb00642.x","article-title":"Further evaluation of the dementia questionnaire for persons with mental retardation (DMR)","volume":"40","author":"Evenhuis","year":"1996","journal-title":"J. Intel Dis. Res."},{"issue":"September (3)","key":"10.1016\/j.neulet.2016.11.023_bib0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bld.12102","article-title":"Interinformant agreement of the dementia questionnaire for people with learning disabilities","volume":"43","author":"Walker","year":"2015","journal-title":"Br. J. Learn. Disabil."},{"key":"10.1016\/j.neulet.2016.11.023_bib0115","series-title":"British Picture Vocabulary Scale","author":"Dunn","year":"1997"},{"issue":"4","key":"10.1016\/j.neulet.2016.11.023_bib0120","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/01688639008400998","article-title":"Object-memory evaluation for prospective detection of dementia in normal functioning elderly: predictive and normative data","volume":"12","author":"Fuld","year":"1990","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"2","key":"10.1016\/j.neulet.2016.11.023_bib0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2788.2000.00264.x","article-title":"Test battery for the diagnosis of dementia in individuals with intellectual disability","volume":"44","author":"Burt","year":"2000","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.neulet.2016.11.023_bib0130","unstructured":"SPSS inc. SPSS for Windows Release 11.0.0. SPSS Inc., 2001."},{"issue":"July (2)","key":"10.1016\/j.neulet.2016.11.023_bib0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neulet.2009.04.020","article-title":"Neopterin and the risk of dementia in persons with Down syndrome","volume":"458","author":"Coppus","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.neulet.2016.11.023_bib0140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bbadis.2011.12.010","article-title":"Antioxidants in down syndrome","volume":"1822","author":"Lott","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neulet.2016.11.023_bib0145","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jnen\/59.11.1011","article-title":"Neuronal oxidative stress precedes amyloid-\u03b2 deposition in Down syndrome","volume":"59","author":"Nunomura","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neulet.2016.11.023_bib0150","article-title":"Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain","author":"Sultana","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neulet.2016.11.023_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03530.x","article-title":"Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease","volume":"96","author":"Reddy","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2016.11.023_bib0160","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","article-title":"Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis","volume":"21","author":"Pratic\u00f2","year":"2001","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neulet.2016.11.023_bib0165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbadis.2011.10.001","article-title":"Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome","volume":"1822","author":"Cenini","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.neulet.2016.11.023_bib0170","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.bbadis.2013.04.013","article-title":"Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer\u2019s Disease neuropathology: redox proteomics analysis of human brain","volume":"1832","author":"Di Domenico","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"May\u2013Jun (3A)","key":"10.1016\/j.neulet.2016.11.023_bib0175","first-page":"1721","article-title":"Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?","volume":"19","author":"Murr","year":"1999","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.neulet.2016.11.023_bib0180","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ab.2008.09.014","article-title":"Neopterin, a marker of immune response, and 8-hydroxy-2'-deoxyguanosine, a marker of oxidative stress, correlate at high age as determined by automated simultaneous high-performance liquid chromatography analysis of human urine","volume":"383","author":"Svoboda","year":"2008","journal-title":"Anal. Biochem."},{"issue":"September (13)","key":"10.1016\/j.neulet.2016.11.023_bib0185","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.clinbiochem.2008.06.008","article-title":"Inflammatory sites as a source of plasma neopterin: measurement of high levels of neopterin and markers of oxidative stress in pus drained from human abscesses","volume":"41","author":"Firth","year":"2008","journal-title":"Clin. Biochem."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016308655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016308655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T10:47:21Z","timestamp":1568544441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394016308655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":37,"alternative-id":["S0304394016308655"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2016.11.023","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive ability in Down syndrome and its relationship to urinary neopterin, a marker of activated cellular immunity","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2016.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}